Teva Pharmaceuticals has announced positive results from its Phase III SOLARIS trial of TEV-749, a long-acting injectable ...

Shanghai-based Fosun Pharmaceutical has acquired the remaining 50% stake in Fosun Kite Biotechnology from Kite Pharma for $27 ...

On Friday, the USA’s Federal Trade Commission (FTC) brought action against the three largest prescription drug benefit ...

The US Food and Drug Administration (FDA) has approved Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) as a first line treatment option for adult patients ...

The Health Sciences Authority (HSA) of Singapore has approved Merck & Co’s Winrevair (sotatercept), for the treatment of ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

The European Commission has conditionally approved the marketing application submitted by Ipsen for Iqirvo (elafibranor) 80mg ...

On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...

Leslie Orne, president and CEO of Trinity Life Sciences, emphasizes the importance of corporate efficiency in the highly ...

US presidential election, health policy will remain a key issue for pharma. Both Donald Trump and Kamala Harris have ...

The UK’s MHRA has approved Takeda’s Fruzaqla (fruquintinib) for metastatic colorectal cancer (CRC) in adults who have not ...

Novo Nordisk has announced positive Phase IIa results for monlunabant, a small molecule oral CB1 inverse agonist for obesity.